Targeted adalimumab treatment can optimize long-term outcomes for patients with early rheumatoid arthritis, study suggests
Links shared publicly online about this topic.
- 265total visits
Targeted adalimumab treatment can optimize long-term outcomes for patients with early rheumatoid arthritis, study suggests
New research shows that initial treatment with adalimumab (Humira, ADA) plus methotrexate in early RA patients can provide high levels of disease control in many patients, and may also offer the opportunity to change future treatment options for some.
View full resource at sciencedaily.com
Tags: Crohn's Disease Medication, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Humira, Rheumatrex, Trexall
Most Recently Shared on May 26, 2011 at 3:54 pm By:
Targeted adalimumab treatment can optimize long-term outcomes for patients with early rheumatoid arthritis, stud... http://bit.ly/iQuQlm
Advertisement
